socalTechnews
Home
Mobile
News and Events
  • Headlines
  • Events
  • Interviews
  • Jobs
  • Directory
    		•
    Members Only
  • Networking
  • Venture Deals
  • Venture Firms
  • Companies
    • About
  • Membership
  • About
  • Contact Us
    		•
    Search News
    Monday, March 24, 2008

    Zogenix Files For IPO
    San Diego-based Zogenix said late last Thursday in a filing with the SEC that it is looking to raise up to $86.25M in an IPO on the Nasdaq Global Market. The firm said it has applied to list as "ZGNX." The IPO is being underwritten by Banc of America Securities, Leerink Swann, Thomas Weisel Partners, and Susquehanna Financial Group. Zogenix develops pharmaceuticals for the treatment of pain and central nervous system disorders; the firm's lead product is an treatment for actue migraines. Zogenix is backed by Domain Associates, Clarus Lifesciences, Scale Venture Partners, Thomas McNerney & Partners, Abingworth Bioventures, and others.
    posted on Monday, March 24, 2008

    Related companies:
    Zogenix

    Related stories:
    > Zogenix Raises $60M
    > Zogenix Gets $10M Loan Facility
    > Zogenix Gains $18M In New Funding
    > Zogenix Appoints VP
    > Bluebeam Launches CAD Conversion Program

    RSS Feed
    subscri be via emailNewsletter


    Previous news:

     Monday, May 19, 2008
    Friday, May 16, 2008
    Thursday, May 15, 2008
    Wednesday, May 14, 2008
    Tuesday, May 13, 2008